Megalin interacts with APP and the intracellular adapter protein FE65 in neurons

Molecular and Cellular Neurosciences
Ximena Alvira-BoteroEva Carro

Abstract

Increasing evidence has implicated megalin, a low-density lipoprotein receptor-related protein, in the pathogenesis of Alzheimer's disease (AD). In the brain, megalin is expressed in brain capillaries, ependymal cells and choroid plexus, where it participates in the clearance of brain amyloid β-peptide (Aβ) complex. Recently, megalin has also been detected in oligodendrocytes and astrocytes. In this study we demonstrate that megalin is widely distributed in neurons throughout the brain. Additionally, given that FE65 mediates the interaction between the low density lipoprotein receptor-related protein-1 and the amyloid precursor protein (APP) to modulate the rate of APP internalization from the cell surface, we hypothesize that megalin could also interact with APP in neurons. Our results confirm that megalin interacts with APP and FE65, suggesting that these three proteins form a tripartite complex. Moreover, our findings imply that megalin may participate in neurite branching. Taken together, these results indicate that megalin has an important role in Aβ-mediated neurotoxicity, and therefore may be involved in the neurodegenerative processes that occur in AD.

References

Apr 1, 1994·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·G ZhengR T McCluskey
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·T E WillnowJ Herz
May 8, 2002·Nature Reviews. Molecular Cell Biology·Erik Ilsø Christensen, Henrik Birn
Apr 3, 2003·Science's STKE : Signal Transduction Knowledge Environment·Petra MayJoachim Herz
Oct 7, 2003·Molecular Biology of the Cell·Masaaki NagaiMarilyn Gist Farquhar
Apr 30, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Claus U PietrzikEdward H Koo
Dec 30, 2004·Development·Robert SpoelgenThomas E Willnow
Nov 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Eva CarroIgnacio Torres-Aleman
Feb 28, 2007·Neurobiology of Aging·Marcelo O DietrichEva Carro
Jul 20, 2007·Experimental Brain Research·Melinda FitzgeraldLyn D Beazley
Feb 22, 2008·Current Alzheimer Research·Sebastian Jaeger, Claus U Pietrzik
Jun 19, 2008·Neurobiology of Disease·Elaine WaldronClaus U Pietrzik
Mar 13, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Carolina E FlemingMónica M Sousa

❮ Previous
Next ❯

Citations

Sep 29, 2011·Experimental Brain Research·Timo Wagner, Claus U Pietrzik
Apr 17, 2012·International Journal of Alzheimer's Disease·Daniel A Bórquez, Christian González-Billault
Apr 7, 2011·Biological & Pharmaceutical Bulletin·Hideki Hayashi
Dec 18, 2013·Cellular and Molecular Life Sciences : CMLS·Marta BolosEva Carro
Feb 4, 2016·Trends in Pharmacological Sciences·Carole DeytsAngèle T Parent
Oct 26, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Li-Ling WangSheng-Di Chen
Apr 9, 2016·Oxidative Medicine and Cellular Longevity·Yiting ZhangRichard Deth
Mar 8, 2014·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Vanessa SchmidtThomas E Willnow
Feb 25, 2015·Developmental Cell·Rik van der Kant, Lawrence S B Goldstein
Apr 24, 2012·Journal of Aging Research·Carlos SpuchCarmen Navarro
Aug 9, 2016·The American Journal of Pathology·Eva TavaresEva Carro
Mar 17, 2017·Frontiers in Molecular Neuroscience·Theresa PohlkampJoachim Herz
Jan 19, 2017·Pediatric Research·Danielle W LoweDorothea Jenkins
Sep 11, 2014·American Journal of Alzheimer's Disease and Other Dementias·Niangui XuZhiling Huang
Jun 21, 2016·Neurología : publicación oficial de la Sociedad Española de Neurología·J Matías-GuíuU Gomez-Pinedo
Dec 6, 2018·Endocrine, Metabolic & Immune Disorders Drug Targets·Adel A HagagAmal E Abd El-Latif
Apr 12, 2013·Expert Opinion on Therapeutic Targets·Henna MartiskainenMikko Hiltunen
Apr 21, 2017·Frontiers in Molecular Neuroscience·Suzanne GuénetteStefan Kins
Jul 3, 2013·Journal of Cell Science·Thomas E Willnow, Olav M Andersen
Jul 3, 2021·Cells·Vanessa Augustin, Stefan Kins
Jul 30, 2021·Ageing Research Reviews·Doortje W DekensPetrus J W Naudé

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.